CYCN - Company ID 0001755237
The table below shows Cyclerion Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.24M | $3.23M | $7.57M | $13.38M | $53.96M | $54.40M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $1.00M | $556.00K | $0.00 | $96.00K | $100.00K | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $4.63M |
| $4.22M |
| $8.02M |
| $14.82M |
| $55.46M |
| $58.50M |
| Property, plant & equipment | - | $0.00 | $0.00 | $0.00 | $65.00K | $6.87M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $9.98M | $9.57M | $13.37M | $18.08M | $59.33M | $115.38M |
| Accounts payable | $508.00K | $390.00K | $1.20M | $2.97M | $1.83M | $1.15M |
| Total current liabilities | $900.00K | $725.00K | $2.09M | $7.63M | $11.09M | $16.95M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$271.02M | -$267.49M | -$264.42M | -$259.15M | -$215.08M | -$163.43M |
| Total equity | $9.09M | $8.85M | $11.29M | $10.45M | $48.25M | $59.49M |